Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-03

Clinical Trial Update: Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy with or without sodium thiosulfate to prevent low platelet counts in malignant glioma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Malignant Glioma | Phase 2 | Status: UNKNOWN